about
Clinical significance of T cell metabolic reprogramming in cancerSignaling Interplay between Bone Marrow Adipose Tissue and Multiple Myeloma cellsEffects of NSAIDs on the risk factors of colorectal cancer: a mini reviewUnexploited Antineoplastic Effects of Commercially Available Anti-Diabetic DrugsArtemisinin and Its Derivatives as a Repurposing Anticancer Agent: What Else Do We Need to Do?Insulin-Sensitizers, Polycystic Ovary Syndrome and Gynaecological Cancer RiskThe neuroleptic drug pimozide inhibits stem-like cell maintenance and tumorigenicity in hepatocellular carcinoma.Reconstruction of pathway modification induced by nicotinamide using multi-omic network analyses in triple negative breast cancer.Tumor mechanics and metabolic dysfunction.Prevention of tumor growth driven by PIK3CA and HPV oncogenes by targeting mTOR signaling with metformin in oral squamous carcinomas expressing OCT3.Nanoparticle formulation of ormeloxifene for pancreatic cancerProlonged Nightly Fasting and Breast Cancer Risk: Findings from NHANES (2009-2010).Targeting AMPK for cancer prevention and treatment.Metformin prevents aggressive ovarian cancer growth driven by high-energy diet: similarity with calorie restriction.Importance of CD200 expression by tumor or host cells to regulation of immunotherapy in a mouse breast cancer model.Metformin inhibits gastric cancer cells metastatic traits through suppression of epithelial-mesenchymal transition in a glucose-independent manner.Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathways.Influence of metformin intake on the risk of bladder cancer in type 2 diabetes patients.Metformin for cancer and aging prevention: is it a time to make the long story short?Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma.Obesity and Cancer: An Angiogenic and Inflammatory Link.Construction of In Vivo Fluorescent Imaging of Echinococcus granulosus in a Mouse Model.Obesity-associated NLRC4 inflammasome activation drives breast cancer progression.Methylglyoxal-Mediated Stress Correlates with High Metabolic Activity and Promotes Tumor Growth in Colorectal Cancer.Sirolimus and metformin synergistically inhibit hepatocellular carcinoma cell proliferation and improve long-term survival in patients with HCC related to hepatitis B virus induced cirrhosis after liver transplantation.The MAGE protein family and cancer.Disruption of mitochondrial electron transport chain function potentiates the pro-apoptotic effects of MAPK inhibition.Metformin use and survival after non-small cell lung cancer: A cohort study in the US Military health system.The effect and mechanism of action of metformin on in vitro FaDu cell proliferation.Combining p53 stabilizers with metformin induces synergistic apoptosis through regulation of energy metabolism in castration-resistant prostate cancer.Relationship Between Breast Density and Selective Estrogen-Receptor Modulators, Aromatase Inhibitors, Physical Activity, and Diet: A Systematic Review.T-cell Metabolism as a Target to Control Autoreactive T Cells in β-Cell Autoimmunity.Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal CancerCancer: Linking Powerhouses to Suicidal Bags.The STAT3 inhibitor pimozide impedes cell proliferation and induces ROS generation in human osteosarcoma by suppressing catalase expressionEmerging Role of Nutri-Epigenetics in Inflammation and CancerHernandezine, a novel AMPK activator induces autophagic cell death in drug-resistant cancersInhibition of P-glycoprotein expression and function by anti-diabetic drugs gliclazide, metformin, and pioglitazone in vitro and in situ.The most important questions in cancer research and clinical oncology-Question 2-5. Obesity-related cancers: more questions than answersNeuro-protective effect of rutin against Cisplatin-induced neurotoxic rat model.
P2860
Q26741974-27BBE3D4-BC86-40CA-A20D-CC46F3F67FECQ26744596-50047835-32B6-489B-81EC-78C175E1F6E3Q26746884-FAC70F40-773F-4222-A1D9-E9BB9744DA96Q26750845-AA7C7739-B53C-481D-87D7-F2FCE06F5C2FQ28066236-0D2E7F20-2FCA-469B-A186-6E5E049A475CQ28072521-F3B2EB93-F3C1-468E-8B0B-09B6FD4A9758Q33566593-7D046AC5-63B4-4D61-B83B-BE8614C3F0E8Q33799624-E7DBD2C2-4BBE-4DC6-8D69-D70F91D0D7CCQ35117423-B23A1909-8BDE-4453-83D5-9F5214439089Q35164428-D437B55E-C336-4939-90C2-761A09EB50CBQ35517037-3BDB839B-2729-4A2F-AEBE-BC6F62D81864Q35563100-92A1A047-B81F-40F4-93D3-BCA464E5ED1DQ35781311-E72EA5A4-2B74-46A3-89C4-AD1D817999DEQ35793665-E7C2E016-E056-41E0-9D01-C266A0D9CE15Q36289546-CB4D5F32-8FC4-4BC9-AD14-CB483E69498AQ36320084-462CACAB-80D5-4398-A4D0-5A3AB831E651Q36361245-0F34F146-CD7D-404B-91A0-7315CD16AF92Q36410079-36362E96-966C-4696-AA26-848D14131681Q36545393-4BE60F2E-34A2-4BEA-B587-761D1413043EQ36729549-49F89117-174D-49C1-B446-7E51D3E8487AQ36759129-910872E7-6A0E-4BD1-B504-18982EFD4A3EQ37160559-108F96C0-9623-4074-9A8E-B8686C804663Q37330542-A97843CA-5FEA-420A-9C9F-0DBCE0605852Q37631704-F223B481-8680-4228-91F9-E536FED400E6Q37641827-798151E7-B8CA-43A0-A3A9-7068BBDE90C3Q38581531-55F88347-81ED-4744-85C5-F3718C87BF27Q38702202-71B207E9-AC16-4713-8471-0B08957C6F44Q38734576-54414D19-E3F7-4DDE-9DAC-28AF3EE2C5EDQ38743053-84121F50-9E1B-42C1-895B-01C4AC8696D9Q38792069-E4681082-B0CC-4D72-B6D9-BCF9CCD91C5FQ38821494-8697AAE8-0837-47C5-BB7C-56CF0727A8E7Q39183146-8FD94195-4238-4403-A19C-B4DF3E5E9BF4Q39519100-EB17BF20-3C98-4251-A9B2-A7D2392FBBC1Q41440316-06BD9DE1-5963-42B8-81B6-8451D903CCF2Q41549450-05EE2748-12D9-4410-A9C6-E84D9AA48950Q41689921-AEE17D86-3EB9-4518-AF11-90DAEA587A01Q42022268-DB428111-9046-4300-A3BC-A647E24F282BQ42092734-A7009666-CE48-4697-9B81-4F2A405DBF3FQ42325041-87B6F5EC-F14E-4C76-A420-F1B9E8E61F38Q42368069-E368D47D-788B-461E-B68B-78D795F1A784
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Metformin in cancer prevention and therapy.
@ast
Metformin in cancer prevention and therapy.
@en
Metformin in cancer prevention and therapy.
@nl
type
label
Metformin in cancer prevention and therapy.
@ast
Metformin in cancer prevention and therapy.
@en
Metformin in cancer prevention and therapy.
@nl
prefLabel
Metformin in cancer prevention and therapy.
@ast
Metformin in cancer prevention and therapy.
@en
Metformin in cancer prevention and therapy.
@nl
P2860
P1476
Metformin in cancer prevention and therapy.
@en
P2093
Agnieszka Sliwinska
Jacek Kasznicki
P2860
P356
10.3978/J.ISSN.2305-5839.2014.06.01
P577
2014-06-01T00:00:00Z